385 related articles for article (PubMed ID: 16517021)
1. Brain regional alterations in the modulation of the glutamate-nitric oxide-cGMP pathway in liver cirrhosis. Role of hyperammonemia and cell types involved.
Rodrigo R; Felipo V
Neurochem Int; 2006; 48(6-7):472-7. PubMed ID: 16517021
[TBL] [Abstract][Full Text] [Related]
2. Neurons exposed to ammonia reproduce the differential alteration in nitric oxide modulation of guanylate cyclase in the cerebellum and cortex of patients with liver cirrhosis.
Rodrigo R; Erceg S; Felipo V
Neurobiol Dis; 2005; 19(1-2):150-61. PubMed ID: 15837570
[TBL] [Abstract][Full Text] [Related]
3. Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease.
Rodrigo R; Montoliu C; Chatauret N; Butterworth R; Behrends S; Del Olmo JA; Serra MA; Rodrigo JM; Erceg S; Felipo V
Neurochem Int; 2004 Nov; 45(6):947-53. PubMed ID: 15312989
[TBL] [Abstract][Full Text] [Related]
4. Bile duct ligation plus hyperammonemia in rats reproduces the alterations in the modulation of soluble guanylate cyclase by nitric oxide in brain of cirrhotic patients.
Rodrigo R; Jover R; Candela A; Compañ A; Sáez-Valero J; Erceg S; Felipo V
Neuroscience; 2005; 130(2):435-43. PubMed ID: 15664700
[TBL] [Abstract][Full Text] [Related]
5. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients.
Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Ferrandez A; Rodrigo JM; Felipo V
J Mol Med (Berl); 2007 Mar; 85(3):237-45. PubMed ID: 17216205
[TBL] [Abstract][Full Text] [Related]
6. Region selective alterations of soluble guanylate cyclase content and modulation in brain of cirrhotic patients.
Corbalán R; Chatauret N; Behrends S; Butterworth RF; Felipo V
Hepatology; 2002 Nov; 36(5):1155-62. PubMed ID: 12395325
[TBL] [Abstract][Full Text] [Related]
7. Altered content and modulation of soluble guanylate cyclase in the cerebellum of rats with portacaval anastomosis.
Monfort P; Corbalán R; Martinez L; López-Talavera J; Córdoba J; Felipo V
Neuroscience; 2001; 104(4):1119-25. PubMed ID: 11457595
[TBL] [Abstract][Full Text] [Related]
8. Glutamate-induced activation of nitric oxide synthase is impaired in cerebral cortex in vivo in rats with chronic liver failure.
Rodrigo R; Erceg S; Rodriguez-Diaz J; Saez-Valero J; Piedrafita B; Suarez I; Felipo V
J Neurochem; 2007 Jul; 102(1):51-64. PubMed ID: 17286583
[TBL] [Abstract][Full Text] [Related]
9. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications.
Erceg S; Monfort P; Cauli O; Montoliu C; Llansola M; Piedrafita B; Felipo V
Neurochem Int; 2006; 48(6-7):441-6. PubMed ID: 16497413
[TBL] [Abstract][Full Text] [Related]
10. Altered modulation of soluble guanylate cyclase by nitric oxide in patients with liver disease.
Corbalán R; Montoliu C; Miñana MD; Del Olmo JA; Serra MA; Aparisi L; Rodrigo JM; Felipo V
Metab Brain Dis; 2002 Dec; 17(4):295-301. PubMed ID: 12602506
[TBL] [Abstract][Full Text] [Related]
11. In vivo exposure to carbon monoxide causes delayed impairment of activation of soluble guanylate cyclase by nitric oxide in rat brain cortex and cerebellum.
Hernández-Viadel M; Castoldi AF; Coccini T; Manzo L; Erceg S; Felipo V
J Neurochem; 2004 Jun; 89(5):1157-65. PubMed ID: 15147508
[TBL] [Abstract][Full Text] [Related]
12. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
Monfort P; Muñoz MD; Kosenko E; Llansola M; Sánchez-Pérez A; Cauli O; Felipo V
Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Protein Kinase A Modulates Intracellular Calcium/Calmodulin-Dependent Protein Kinase II, Nitric Oxide Synthase, and the Glutamate-Nitric Oxide-cGMP Pathway in Cerebellum. Differential Effects in Hyperammonemia.
Cabrera-Pastor A; Llansola M; Felipo V
ACS Chem Neurosci; 2016 Dec; 7(12):1753-1759. PubMed ID: 27673574
[TBL] [Abstract][Full Text] [Related]
14. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo.
Hermenegildo C; Montoliu C; Llansola M; Muñoz MD; Gaztelu JM; Miñana MD; Felipo V
Eur J Neurosci; 1998 Oct; 10(10):3201-9. PubMed ID: 9786213
[TBL] [Abstract][Full Text] [Related]
15. Chronic hyperammonemia in rats impairs activation of soluble guanylate cyclase in neurons and in lymphocytes: a putative peripheral marker for neurological alterations.
Miñana MD; Corbalán R; Montoliu C; Teng CM; Felipo V
Biochem Biophys Res Commun; 1999 Apr; 257(2):405-9. PubMed ID: 10198226
[TBL] [Abstract][Full Text] [Related]
16. Hyperammonemia alters glycinergic neurotransmission and modulation of the glutamate-nitric oxide-cGMP pathway by extracellular glycine in cerebellum in vivo.
Cabrera-Pastor A; Taoro-Gonzalez L; Felipo V
J Neurochem; 2016 May; 137(4):539-48. PubMed ID: 26875688
[TBL] [Abstract][Full Text] [Related]
17. Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications.
Montoliu C; Rodrigo R; Monfort P; Llansola M; Cauli O; Boix J; Elmlili N; Agusti A; Felipo V
Metab Brain Dis; 2010 Mar; 25(1):39-48. PubMed ID: 20195723
[TBL] [Abstract][Full Text] [Related]
18. Umbelliferone prevents oxidative stress, inflammation and hematological alterations, and modulates glutamate-nitric oxide-cGMP signaling in hyperammonemic rats.
Germoush MO; Othman SI; Al-Qaraawi MA; Al-Harbi HM; Hussein OE; Al-Basher G; Alotaibi MF; Elgebaly HA; Sandhu MA; Allam AA; Mahmoud AM
Biomed Pharmacother; 2018 Jun; 102():392-402. PubMed ID: 29573618
[TBL] [Abstract][Full Text] [Related]
19. Polychlorinated biphenyls PCB 52, PCB 180, and PCB 138 impair the glutamate-nitric oxide-cGMP pathway in cerebellar neurons in culture by different mechanisms.
Llansola M; Montoliu C; Boix J; Felipo V
Chem Res Toxicol; 2010 Apr; 23(4):813-20. PubMed ID: 20297801
[TBL] [Abstract][Full Text] [Related]
20. Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR-2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices.
Zielińska M; Fresko I; Konopacka A; Felipo V; Albrecht J
Neurotoxicology; 2007 Nov; 28(6):1260-3. PubMed ID: 17629948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
